TT
Turn Therapeutics Inc.
TTRX · NASDAQ
$14.94 +8.26% (+$1.14)
1M +57.93%
Market Cap $411.7M
P/E Ratio -
Div. Yield -
ROE 280.41%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 599.33x
PEG N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 280.41%
ROA 49.80%
Asset turnover 0.00x
Debt
11 /100
High Current ratio 1.19x
Int. coverage -17.50x
Debt/Equity 8.91x
Stability
0 /100
Unstable Beta 2.05x
EPS volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TTRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bradley E. Burnam
Employees
2
Headquarters
Westlake Village
Evenimente viitoare
12 NOV.
Earnings
Upcoming earnings report